Titan Pharmaceuticals, Inc. (de)

NASDAQ:TTNP 4:00:00 PM EDT

4.73

-0.27 (-5.40%)

7:58:07 PM EDT: $4.40 -0.33 (-6.98%)

Titan Pharmaceuticals, Inc. (de) Stock, NASDAQ:TTNP

400 Oyster Point Boulevard, Suite 505, South San Francisco, California 94080-1958

United States of America

Phone: +1.650.244.4990

Number of Employees: 4

http://www.titanpharm.com

Description

Titan Pharmaceuticals, Inc. engages in the development of therapeutics for the treatment of chronic diseases utilizing its long-term, continuous drug delivery platform, proNeura. Its lead product is probuphine, a buprenorphine implant for the maintenance treatment of opioid addiction. The company was founded by Louis R. Bucalo on February 7, 1992 and is headquartered in South San Francisco, CA.